Insmed (INSM) Shares Outstanding (Weighted Average) (2010 - 2026)

Insmed's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $215.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 19.14% year-over-year to $215.5 million; the TTM figure through Mar 2026 stood at $215.5 million (up 19.14% YoY), while the FY2025 annual figure was $199.0 million, up 21.32% from the prior year.
• Shares Outstanding (Weighted Average) was $215.5 million for Q1 2026 at Insmed, up from $199.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $215.5 million in Q1 2026 to a low of $118.9 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $156.3 million across 5 years, with a median of $148.5 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) gained 3.16% in 2022, then surged 33.17% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $123.0 million in 2022, then rose by 14.14% to $140.4 million in 2023, then advanced by 16.81% to $164.0 million in 2024, then increased by 21.32% to $199.0 million in 2025, then gained by 8.27% to $215.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $215.5 million (Q1 2026), $199.0 million (Q4 2025), and $211.8 million (Q3 2025), per Business Quant data.